Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Lake

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|March 22, 2007
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicityDavid F V Lewis, Brian G Lake, Maurice Dickins
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 14, 2005
Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activityDavid F V Lewis, Brian G Lake, Michael G Bird
Drug Metabolism and Drug Interactions|July 18, 2006
Quantitative structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolismDavid F V Lewis, Brian G Lake, Yuko Ito, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 25, 2006
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymesDavid F V Lewis, Brian G Lake, Yuko Ito, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 20, 2013
Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humansThomas G Osimitz, Wiebke Droege, Alan R Boobis, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 20, 2008
In vitro assays for induction of drug metabolismBrian G Lake, Roger J Price, Amanda M Giddings, et al.
Drug Metabolism and Drug Interactions|December 20, 2003
A molecular model of CYP2D6 constructed by homology with the CYP2C5 crystallographic template: investigation of enzyme-substrate interactionsDavid F V Lewis, Maurice Dickins, Brian G Lake, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Dose-related effects of the peroxisome proliferator methylclofenapate in rat liverBrian G Lake, Paul C Rumsby, Morag E Cunninghame, et al.
Drug Metabolism and Drug Interactions|May 20, 2003
Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactionsDavid F V Lewis, Brian G Lake, Maurice Dickins, et al.
Drug Metabolism and Drug Interactions|February 11, 2004
Investigation of enzyme selectivity in the human CYP2C subfamily: homology modelling of CYP2C8, CYP2C9 and CYP2C19 from the CYP2C5 crystallographic templateDavid F V Lewis, Maurice Dickins, Brian G Lake, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Enzyme Inhibition and Medicinal Chemistry|March 22, 2007
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicityDavid F V Lewis, Brian G Lake, Maurice Dickins
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 14, 2005
Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activityDavid F V Lewis, Brian G Lake, Michael G Bird
Drug Metabolism and Drug Interactions|July 18, 2006
Quantitative structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolismDavid F V Lewis, Brian G Lake, Yuko Ito, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 25, 2006
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymesDavid F V Lewis, Brian G Lake, Yuko Ito, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 20, 2013
Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humansThomas G Osimitz, Wiebke Droege, Alan R Boobis, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 20, 2008
In vitro assays for induction of drug metabolismBrian G Lake, Roger J Price, Amanda M Giddings, et al.
Drug Metabolism and Drug Interactions|December 20, 2003
A molecular model of CYP2D6 constructed by homology with the CYP2C5 crystallographic template: investigation of enzyme-substrate interactionsDavid F V Lewis, Maurice Dickins, Brian G Lake, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Dose-related effects of the peroxisome proliferator methylclofenapate in rat liverBrian G Lake, Paul C Rumsby, Morag E Cunninghame, et al.
Drug Metabolism and Drug Interactions|May 20, 2003
Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactionsDavid F V Lewis, Brian G Lake, Maurice Dickins, et al.
Drug Metabolism and Drug Interactions|February 11, 2004
Investigation of enzyme selectivity in the human CYP2C subfamily: homology modelling of CYP2C8, CYP2C9 and CYP2C19 from the CYP2C5 crystallographic templateDavid F V Lewis, Maurice Dickins, Brian G Lake, et al.
Pageof 8